These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7896039)

  • 1. Metallothionein in carcinogenesis and cancer chemotherapy.
    Ebadi M; Iversen PL
    Gen Pharmacol; 1994 Nov; 25(7):1297-310. PubMed ID: 7896039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metallothionein].
    Naganuma A
    Nihon Rinsho; 1997 May; 55(5):1091-5. PubMed ID: 9155158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy.
    Doz F; Roosen N; Rosenblum ML
    J Neurooncol; 1993 Aug; 17(2):123-9. PubMed ID: 8145055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of metallothionein in carcinogenesis.
    Cherian MG; Howell SB; Imura N; Klaassen CD; Koropatnick J; Lazo JS; Waalkes MP
    Toxicol Appl Pharmacol; 1994 May; 126(1):1-5. PubMed ID: 8184419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of metallothionein confers resistance to anticancer drugs.
    Kelley SL; Basu A; Teicher BA; Hacker MP; Hamer DH; Lazo JS
    Science; 1988 Sep; 241(4874):1813-5. PubMed ID: 3175622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein expression and transient resistance to electrophilic antineoplastic drugs.
    Lazo JS; Basu A
    Semin Cancer Biol; 1991 Aug; 2(4):267-71. PubMed ID: 1912530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective function of metallothionein against certain anticancer agents.
    Endresen L; Rugstad HE
    Experientia Suppl; 1987; 52():595-602. PubMed ID: 2959550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of zinc, copper, and metallothionein in cancer patients.
    Ebadi M; Swanson S
    Prog Clin Biol Res; 1988; 259():161-75. PubMed ID: 3283743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of metallothionein in cancer chemotherapy].
    Naganuma A; Imura N
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):301-6. PubMed ID: 8109985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs.
    Basu A; Lazo JS
    Toxicol Lett; 1990 Feb; 50(2-3):123-35; discussion 121-2. PubMed ID: 2408195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
    Koropatnick J; Pearson J
    Mol Pharmacol; 1993 Jul; 44(1):44-50. PubMed ID: 8341278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metallothionein as a resistance factor for antitumor drugs].
    Imura N; Naganuma A; Satoh M
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):599-604. PubMed ID: 2705789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metallothionein and cancer].
    Li X; Ru B
    Wei Sheng Yan Jiu; 1999 May; 28(3):185-7. PubMed ID: 12712730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of metallothionein gene expression by oxidative stress and metal ions.
    Andrews GK
    Biochem Pharmacol; 2000 Jan; 59(1):95-104. PubMed ID: 10605938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothioneins in human tumors and potential roles in carcinogenesis.
    Cherian MG; Jayasurya A; Bay BH
    Mutat Res; 2003 Dec; 533(1-2):201-9. PubMed ID: 14643421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure and function of metallothionein].
    Suzuki KT
    Nihon Rinsho; 1996 Jan; 54(1):33-9. PubMed ID: 8587202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plasmid containing the human metallothionein II gene can function as an antibody-assisted electrophoretic biosensor for heavy metals.
    Wooten DC; Starr CR; Lyon WJ
    J Immunotoxicol; 2016; 13(1):55-63. PubMed ID: 25594566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oncogenes on the resistance to cis-diamminedichloroplatinum(II) and metallothionein gene expression.
    Yamada-Okabe T; Yamada-Okabe H; Kashima Y; Doi R
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):233-8. PubMed ID: 7645018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of metallothioneins in anticancer drug resistance.
    Bahnson RR; Basu A; Lazo JS
    Cancer Treat Res; 1991; 57():251-60. PubMed ID: 1686720
    [No Abstract]   [Full Text] [Related]  

  • 20. Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.
    Morton KA; Jones BJ; Sohn MH; Datz FL; Lynch RE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):697-702. PubMed ID: 8246143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.